How do NK cells sense the expression of HLA-G class Ib molecules?

Seminars in Cancer Biology

Volumn 9, Issue 1, 1999, Pages 19-26

  López Botet, Miguel ^a   Navarro, Francisco ^b   Llano, Manuel ^b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b NONE

Author keywords

CD94; HLA E; HLA G; NK cell; Trophoblast

Indexed keywords

CD94 ANTIGEN; CELL RECEPTOR; HLA G ANTIGEN; IMMUNOGLOBULIN;

ARTICLE; HUMAN; HUMAN CELL; LIGAND BINDING; NATURAL KILLER CELL; RECEPTOR BINDING;

EID: 0033081770     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1998.0107     Document Type: Article

References (70)

1. Ljunggren HG, Karre K (1990) In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11:237-244
2. Raulet DH, Held W (1995) Natural killer cell receptors: The offs and ons of NK cell recognition. Cell 82:697-700
3. Zimmer J, Donato L, Hanau D, Cazenave JP, Tongio MM, Moretta A, de lS (1998) Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). J Exp Med 187:117-122
4. Moretta A, Bottino G, Vitale M, Pende D, Biassoni R, Mingari MC, Moretta L (1996) Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol 14:619-648
5. Moretta A, Moretta L (1997) HLA class I specific inhibitory receptors. Curr Opin Immunol 9:694-701
6. Pessino A, Sivori S. Bottino C, Malaspina A, Morelli L, Moretta L, Biassoni R, Moretta A (1998) Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med 188:953-960
7. Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, Marcenaro E, Augugliaro R, Moretta L, Moretta A (1998) NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 187:2065-2072
8. Le Bouteiller P, Lenfant F (1996) Antigen-presenting function(s) of the non-classical HLA-E, -F and -G class I molecules: The beginning of a story. Res Immunol 147:301-313
9. Lee N, Malacko AR, Ishitani A, Chen MC, Bajorath J, Marquardt H, Geraghty DE (1995) The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3:591-600
10. Onno M, Guillaudeux T, Amiot L, Renard I, Drenou B, Hirel B, Girr M, Semana G, Le Bouteiller P, Fauchet R (1994) The HLA-G gene is expressed at a low mRNA level in different human cells and tissues. Hum Immunol 41:79-86
11. Parham P (1995) Antigen presentation by class I major histocompatibility complex molecules: A context for thinking about HLA-G. Am J Reprod Immunol 34:10-19
12. Carosella ED, Dausset J, Kirszenbaum M (1996) HLA-G revisited. Immunol Today 17:407-409
13. Crisa L, McMaster MT, Ishii JK, Fisher SJ, Salomon DR (1997) Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 186:289-298
14. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL (1998) Prevention of allogeneic fetal rejection by tryptophan. Science 281:1191-1193
15. Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le GF, Avril MF, Dausset J, Guillet JG, Carosella ED (1998) HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 95:4510-4515
16. King A, Hiby SE, Verma S, Burrows T, Gardner L, Loke YW (1997) Uterine NK cells and trophoblast HLA class I molecules. Am J Reprod Immunol 37:459-462
17. King A, Burrows T, Loke YW (1996) Human uterine natural killer cells. Nat Immun 15:41-52
18. Ober C, Aldrich C, Rosinsky B, Robertson A, Walker MA, Willadsen S, Verp MS, Geraghty DE, Hunt JS (1998) HLA-G1 protein expression is not essential for fetal survival. Placenta 19:127-132
19. Mandelboim O, Pazmany L, Davis DM, Valés-Gómez M, Reyburn HT, Rybalov B, Strominger JL (1997) Multiple receptors for HLA-G on human natural killer cells. Proc Natl Acad Sci USA 94:14666-14670
20. Pazmany L, Mandelboim O, Valés-Gómez M, Davis DM, Reyburn HT, Strominger JL (1996) Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 274:792-795
21. Munz C, Holmes N, King A, Loke YW, Colonna M, Schild H, Rammensee HG (1997) Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med 185:385-391
22. Pérez-Villar JJ, Melero I, Navarro F, Carretero M, Bellón T, Llano M, Colonna M, Geraghty DE, López-Botet M (1997) The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol 158:5736-5743
23. Pende D, Sivori S, Accame L, Pareti L, Falco M, Geraghty D, Le Bouteiller P, Moretta L, Moretta A (1997) HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. Eur J Immunol 27:1875-1880
24. Söderström K, Corliss B, Lanier LL, Phillips JH (1997) CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. J Immunol 159:1072-1075
25. Colonna M, Samaridis J (1995) Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268:405-408
26. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati MS, Vitale M, Bottino C, Moretta L, Moretta A, Long EO (1995) Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra-and intracellular domains. Immunity 2:439-449
27. Lanier LL (1998) NK cell receptors. Annu Rev Immunol 16:359-393
28. Long EO, Wagtmann N (1997) Natural killer cell receptors. Curr Opin Immunol 9:344-350
29. Leibson PJ (1997) Signal transduction during natural killer cell activation: Inside the mind of a killer. Immunity 6:655-661
30. Vivier E, Daeron M (1997) Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 18:286-291
31. Olcese L, Cambiaggi A, Semenzato G, Bottino C, Moretta A, Vivier E (1997) Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells. J Immunol 158:5083-5086
32. Lanier LL, Corliss BC, Wu J, Leong C, Phillips JH (1998) Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391:703-707
33. Verma S, King A, Loke YW (1997) Expression of killer cell inhibitory receptors on human uterine natural killer cells. Eur J Immunol 27:979-983
34. Hiby SE, King A, Sharkey AM, Loke YW (1997) Human uterine NK cells have a similar repertoire of killer inhibitory and activatory receptors to those found in blood, as demonstrated by RT-PCR and sequencing. Mol Immunol 34:419-430
35. Selvakumar A, Steffens U, Dupont B (1996) NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains. Tissue Antigens 48:285-294
36. Cantoni C, Verdiani S, Falco M, Pessino A, Cilli M, Conte R, Pende D, Mikaelsson MS, Moretta L, Biassoni R (1998) P49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol 28:1980-1990
37. Chumbley G, King A, Robertson K, Holmes N, Loke YW (1994) Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells. Cell Immunol 155:312-322
38. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED (1997) Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 94:11520-11525
39. Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED (1997) The alphal domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA 94:5249-5254
40. Samaridis J, Colonna M (1997) Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways. Eur J Immunol 27:660-665
41. Colonna M, Navarro F, Bellón T, Llano M, García P, Samaridis J, Angman L, Cella M, López-Botet M (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186:1809-1818
42. Borges L, Hsu ML, Fanger N, Kubin M, Cosman D (1997) A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. J Immunol 159:5192-5196
43. Cosman D, Fanger N, Borges L, Kubin M, Chin W, Peterson L, Hsu ML (1997) A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7:273-282
44. Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan CA, Dunbar R, Ogg GS, Cerundolo V, Rolink A (1998) Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 160:3096-3100
45. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, López-Botet M, Geraghty D (1998) HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 95:5199-5204
46. Navarro F, Llano M, Bellón T, Colonna M, Geraghty DE, López-Botet M (1999) The ILT2 (LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol, in press
47. Lopez-Botet M, Carretero M, Bellon T, Perez-Villar JJ, Llano M, Navarro F (1998) The CD94/NKG2 C-type lectin receptor complex. Curr Top Microbiol Immunol 230:41-52
48. Carretero M, Cantoni C, Bellón T, Bottino C, Biassoni R, Rodríguez A, Pérez-Villar J, Moretta L, Moretta A, López-Botet M (1997) The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol 27:563-567
49. Lazetic S, Chang C, Houchins JP, Lanier LL, Phillips JH (1996) Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol 157:4741-4745
50. Pérez-Villar JJ, Melero I, Rodríguez A, Carretero M, Aramburu J, Sivori S, Orengo AM, Moretta A, López-Botet M (1995) Functional ambivalence of the Kp43 (CD94) NK cell-associated surface antigen. J Immunol 154:5779-5788
51. Pérez-Villar JJ, Carretero M, Navarro F, Melero I, Rodríguez A, Bottino C, Moretta A, López-Botet M (1996) Biochemical and serologic evidence for the existence of functionally distinct forms of the CD94 NK cell receptor. J Immunol 157:5367-5374
52. Cantoni C, Biassoni R, Pende D, Sivori S, Accame L, Pareti L, Semenzato G, Moretta L, Moretta A, Bottino C (1998) The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Eur J Immunol 28:327-338
53. Houchins JP, Lanier LL, Niemi EC, Phillips JH, Ryan JC (1997) Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. J Immunol 158:3603-3609
54. Lanier LL, Corliss B, Wu J, Phillips JH (1998) Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 8:693-701
55. Moretta A, Vitale M, Sivori S, Bottino C, Morelli L, Augugliaro R, Barbaresi M, Pende D, Ciccone E, López-Botet M, Moretta L (1994) Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med 180:545-555
56. Phillips JH, Chang C, Mattson J, Gumperz JE, Parham P, Lanier LL (1996) CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. Immunity 5:163-172
57. Sivori S, Vitale M, Bottino C, Marcenaro E, Sanseverino L, Parolini S, Moretta L, Moretta A (1996) CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: Identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. Eur J Immunol 26:2487-2492
58. Braud VM, Allan DS, O'Callaghan CA, Söderström K, D'Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL, McMichael AJ (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391:795-799
59. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG (1998) Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 187:813-818
60. Carretero M, Palmieri G, Llano M, Tullio V, Santoni A, Geraghty DE, López-Botet M (1998) Specific engagement of the CD94/NKG2A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2A: Evidence for receptor function in heterologous transfectants. Eur J Immunol 28:1280-1291
61. Lee N, Goodlett DR, Ishitani A, Marquardt H, Geraghty DE (1998) HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J Immunol 160:4951-4960
62. Braud V, Jones EY, McMichael A (1997) The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9. Eur J Immunol 27:1164-1169
63. O'Callaghan CA, Tormo J, Willcox BE, Braud V, Jakobsen BK, Stuart DI, McMichael A, Green DR (1998) Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol Cell 1:531-541
64. Vance RE, Tanamachi DM, Hanke T, Raulet DH (1997) Cloning of a mouse homolog of CD94 extends the family of C-type lectins on murine natural killer cells. Eur J Immunol 27:3236-3241
65. Dissen E, Berg SF, Westgaard IH, Fossum S (1997) Molecular characterization of a gene in the rat homologous to human CD94. Eur J Immunol 27:2080-2086
66. Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH (1998) Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1. J Exp Med 188:1841-1848
67. Llano M, Lee N, Navarro F, García P, Albar JP, Geraghty D, López-Botet M (1998) HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: Preferential response to an HLA-G-derived nonamer. Eur J Immunol 28:2854-2863.
68. Wolf PR, Cook RG (1995) The class I-b molecule Qa-1 forms heterodimers with H-2Ld and a novel 50-kD glycoprotein encoded centromeric to I-E beta. J Exp Med 181:657-668
69. King A, Boocock C, Sharkey AM, Gardner L, Beretta A, Siccardi AG, Loke YW (1996) Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast. J Immunol 156:2068-2076
70. McMaster M, Zhou Y, Shorter S, Kapasi K, Geraghty D, Lim KH, Fisher S (1998) HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation. J Immunol 160:5922-5928